Mice are resistant to the induction of a pleurodesis.

1 Antoniou KM, Ferdoutsis E, Bouros D. Interferons and their application in the diseases of the lung. Chest 2003; 123:209–216 2 Interferonin the idiopathic hypereosinophilic syndrome: consideration of five cases. Ann Hematol 1998; 77:161–164 3 Baratta L, Afeltra A, Delfino M, et al. Favorable response to high-dose interferonin idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy: case report and literature review. Angiology 2002; 53:465–470 4 Yoon TY, Ahn GB, Chang SH. Complete remission of hypereosinophilic syndrome after interferontherapy: report of a case and literature review. J Dermatol 2000; 27:110–115 5 Tatsis E, Schnabel A, Gross WL. Interferon treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 1998; 129:370–374 6 Lesens O, Hansmann Y, Nerson J, et al. Severe Churg-Strauss syndrome with mediastinal lymphadenopathy treated with interferon therapy. Eur J Intern Med 2002; 13:458 7 Termeer CC, Simon JC, Schopf E. Low-dose interferon-2b for the treatment of Churg Strauss syndrome with prominent skin involvement. Arch Dermatol 2001; 137:136–138